Latest Industry Insights

Elsevier’s “Insights 2024: Attitudes toward AI” report reveals how researchers feel about AI and what is needed to increase trust in these tools. Here, Mirit Eldor, managing director, life sciences at Elsevier discusses these findings further.

In this article, JoJo Platt and Ruthi Aladjem from Corundum Neuroscience discuss why 2024 is the year for brain-computer interfaces.

In this interview, Dr. Hui Jiang explores her inspirations and achievements and gives advice to women starting a career in the science industry.

Tom Mason describes how electrolysis technology upgrades and collaborative efforts are required to boost green hydrogen production and meet rising demand.

At SLAS Europe 2024, Technology Networks had the pleasure of speaking with Jeroen Verheyen, CEO of Semarion, to discuss their award-winning work and how technological innovations advance research.

Two winners earned the New Product Award at SLAS Europe 2024: SEED Biosciences’ Dispen3D and Cryologyx’s PlateReady™. Technology Networks spoke with CEO of CryoLogyx Tom Congdon to learn more about their award-winning new product.

Western blotting is a staple technique in many laboratories but can be time consuming and inconsistent. Technology Networks spoke with Harsha Rao to learn more about Stain-Free western blotting and the advantages of total protein normalization.

This article highlights advancements in neurotechnology that were recently presented in three papers at the 2024 VLSI conference.

To learn more about the FDA's pending decision on MDMA-assisted therapy for PTSD, Technology Networks interviewed Dr. Sam Clark, CEO of Terran Biosciences, who leads one of the industry’s largest psychedelic development programs.

At SLAS Europe 2024, Technology Networks had the pleasure of speaking with Tim Dillon, market manager (Nordics) at Mettler-Toledo Rainin, to learn about how more sustainable options can be implemented into scientists’ daily workflows.